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In the presence of functional DNA repair pathways, DNA double-strand breaks (DSBs) are
mainly repaired by non-homologous end-joining (NHEJ) or homologous recombination (HR),
two conserved pathways that protect cells from aberrant chromosomal rearrangements.
During the past two decades however, unusual and presumably distinct DNA end-joining
repair activities have been unraveled in NHEJ-deﬁcient cells and these are likely to operate
in various chromosomal contexts and species. Most alternative DNA end-joining events
reported so far appear to involve microhomologous sequences and are likely to rely
on a subset of HR enzymes, namely those responsible for the single-strand annealing
mechanism of HR, and on DNA Ligase III. Usually, microhomologies are not initially present
at DSB ends and thus need to be unmasked through DNA end resection, a process
that can lead to extensive nucleotide loss and is therefore highly mutagenic. In addition
to microhomology-mediated end-joining events, recent studies in mammalian cells point
toward the existence of a distinct and still ill deﬁned alternative end-joining pathway that
does not appear to rely on pre-existing microhomologies and may possibly involve DNA
Ligase I. Whether dependent on microhomologies or not, alternative DNA end-joining
mechanisms are likely to be highly mutagenic in vivo, being able to drive telomere fusion
events and cancer-associated chromosomal translocations in mouse models. In the future,
it will be important to better characterize the genetic requirements of these mutagenic
alternative mechanisms of DNA end-joining.
Keywords: double-strand break, non-homologous end-joining, alternative end-joining, microhomology-mediated
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INTRODUCTION
Double-strand breaks (DSBs) represent major threats to genome
integrity. They can be induced during normal metabolism or may
result from the presence of exogenous genotoxic agents like ion-
izing radiations or chemotherapeutic drugs. Cells have evolved
two main pathways to repair these lesions: the non-homologous
end-joining (NHEJ) pathway, that ensures direct resealing of DNA
ends; and thehomologous recombination (HR)pathway that relies
on the presence of homologous DNA sequences for DSB repair.
Repair through HR is not deﬁned by a unique mechanism but
operates through various mechanistically distinct DSB repair pro-
cesses including synthesis-dependent strand annealing (SDSA),
double Holliday junction resolution, and single-strand annealing
(SSA; Paques and Haber, 1999; Chapman et al., 2012; Figure 1).
The common step for HR-dependent DSB repair mechanisms is
the initial formation of single-stranded DNA (ssDNA) for pairing
with homologous DNA template sequences. These HR-dependent
mechanisms of DSB repair have been extensively reviewed pre-
viously and will not be detailed here (Paques and Haber, 1999;
Chapman et al., 2012).
Until very recently, how cells choose between NHEJ and HR-
dependent pathways for DSB repair was still unclear, although
both the cell cycle stage and the nature of DSB ends were pre-
viously involved (Symington and Gautier, 2011; Chapman et al.,
2012). A critical determinant for the choice is provided by the
5′–3′ resection of DNA ends that, while triggering HR-dependent
repair, prevents NHEJ. On the contrary, direct binding at DSB
ends of the conserved Ku70/Ku80 heterodimer, a key complex
of the NHEJ pathway that protects DNA ends against exonucle-
ases, represses HR-dependent mechanisms (Pierce et al., 2001).
Four studies recently shed new light on this important ques-
tion of initial choice between NHEJ and HR for DSB repair
and provided consistent evidences in favor of the existence of
a tightly regulated mechanism (Chapman et al., 2013; Di Vir-
gilio et al., 2013; Escribano-Diaz et al., 2013; Zimmermann et al.,
2013). Four proteins were shown to play critical roles in repair
pathway choice: RIF1 (Rap1-interacting factor 1), 53BP1 (p53
binding protein 1), BRCA1 (breast cancer type 1 susceptibility
protein), and CtIP (C terminus-binding protein-interacting pro-
tein). Brieﬂy, it appears that, while 53BP1–RIF1 stimulates NHEJ,
BRCA1 and CtIP together promote DNA end resection and HR.
RIF1 is indeed recruited to DSB ends via an interaction with
53BP1 and both proteins cooperate to promote NHEJ in G1 cells.
During G2, RIF1/53BP1 binding to DNA ends is repressed by
BRCA1, ensuring a switch to HR during this stage of the cell cycle.
Collectively, these studies provide strong evidences in favor of
well-regulated competitions between NHEJ and HR pathways at
DNA ends.
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FIGURE 1 | Main pathways of DNA repair. Non-homologous end-joining
(NHEJ) and homologous recombination (HR) pathways act competitively to
repair DNA double-strand breaks (DSBs). Key players of NHEJ and HR are
depicted. The MRE11/RAD50/XRS2 (MRX) complex is recruited very early
at DNA ends and appears to play important roles for both NHEJ and HR.
Ku70/Ku80 heterodimer is required for NHEJ and, through inhibition of
DNA end resection (5′–3′ exo), acts as a repressor of HR. Fidelity of
NHEJ-dependent DSB repair is low and, most of the time, associated with
nucleotide deletions and/or insertions at repair junctions. The common early
step of HR-dependent mechanisms is the formation of ssDNA which is then
coated by replication protein A (RPA). Single-strand annealing (SSA)
mechanism requires the presence of direct repeats (shown in orange) on both
sides of the break. SSA does not imply any strand invasion process and is
therefore not dependent on RAD51 protein. Strand invasion and D-loop
formation are however common steps of synthesis-dependent strand
annealing (SDSA) and double Holliday junction (HJ) dissolution mechanisms.
In the latter case, double Holliday junctions are resolved with or without
crossing-over.
The choice of DSB repair pathway inevitably impacts on
the ﬁdelity of repair. Indeed, while HR is generally viewed
as a conservative DSB repair pathway, NHEJ operates with
poor ﬁdelity and nucleotide deletions and/or insertions are fre-
quently detected at repair junctions (Figure 1). However, not
all HR-dependent mechanisms display high ﬁdelity of repair.
Namely, the SSA mechanism requires annealing at two directly
repeated DNA sequences near DSB ends. Consequently, inter-
vening nucleotides initially present between the direct repeat
sequences ﬂanking the break are lost during SSA-mediated repair
(Figure 1).
More recently, backup pathways for DNA repair were identiﬁed
in NHEJ-deﬁcient cells of various organisms. Although it is
still unclear whether only one or several backup repair path-
ways exist, they do not rely on large homologous DNA templates
such as those involved in HR-dependent repair events and are
therefore referred to as “alternative end-joining” pathways. How-
ever, alternative end-joining mechanisms usually -but not always-
rely on the presence of microhomologies at or near DSB ends,
suggesting that these repair events may not be entirely distinct
from HR-dependent mechanisms. Here, I review the history
of alternative end-joining discovery and the recent evidences
that these alternative end-joining events are able to drive class
switch recombination in the immune system, telomere fusions
and chromosomal translocations in vivo.
ALTERNATIVE END-JOINING REPAIR: ONE OR MORE BACKUP
PATHWAY(S)?
Proteins required for NHEJ include -but are not restricted to-
the highly conserved Ku70/Ku80 heterodimeric complex, DNA-
dependent protein kinase catalytic subunit (DNA-PKcs) and DNA
Ligase IV (LIG4) in complex with XRCC4 (Weterings and Chen,
2008). By directly binding DNA ends, Ku70/Ku80 ensures pro-
tection against exonucleases and, as such, acts as an inhibitor
of HR (Figure 1). In 1996, thanks to the use of Ku70-deﬁcient
budding yeast mutants, Boulton and Jackson provided the ﬁrst
evidences for the existence of an alternative DNA end-joining
pathway. This pathway was about 20-fold less efﬁcient than
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NHEJ and repair junctions displayed both nucleotide deletions
and overlapping microhomologies of 3–16 nucleotides (Boulton
and Jackson, 1996). Although it was known at that time that
short microhomologous regions of up to ﬁve nucleotides were
commonly recovered at NHEJ repair junctions of mammalian
cells (Roth et al., 1985), this DNA repair pathway was clearly
able to operate in a NHEJ-deﬁcient background. Supporting the
existence of a new DNA end-joining pathway, biochemical frac-
tionationof calf thymus extracts yielded two fractionswithdistinct
DSB repair activities (Mason et al., 1996). One fraction, presum-
ably enriched for microhomology-mediated end-joining (MMEJ)
activity, was clearly relying on the presence, on both sides of the
DSB, of short repeat sequences. The second fraction, contain-
ing the NHEJ activity, was characterized by the presence of a
DNA ﬁll-in activity -inhibited by DNA polymerase inhibitors-
and the ability to perform ligation of non-homologous DNA
fragments (Mason et al., 1996). In agreement with the previ-
ous suggestion that very short sequence homologies are likely
to help DNA end alignment prior to NHEJ-dependent repair
(Roth et al., 1985; Roth and Wilson, 1986), some repair junc-
tions produced by the NHEJ activity-containing fraction were
also characterized by the presence of overlapping microhomolo-
gies. However, the remaining repair junctions were devoid of
any microhomology, indicating that microhomologies were not
strictly required for NHEJ in this system (Mason et al., 1996).
Later on, backup pathways of end-joining were identiﬁed in var-
ious NHEJ-deﬁcient mammalian cells (Kabotyanski et al., 1998;
Feldmann et al., 2000; Wang et al., 2003).
Whether this newly identiﬁed backup MMEJ pathway was
involving anew set of DNArepair proteinswas unclear at that time.
In 1994, and although they were working in a NHEJ-proﬁcient
budding yeast background, the groupof Haber ﬁrst postulated that
microhomology-mediated DNA repair events may occur through
a RAD52-dependent SSA-type mechanism (Kramer et al., 1994).
The same group then reported that the lower limit for SSA-
dependent DSB repair was lying between 5 and 29 bp of homology,
showing that sequence homologiesmay be very low forHR, at least
in budding yeast (Sugawara et al., 2000). They suggested however,
that some differences may exist between classical SSA, involving
large direct repeats, and “micro-SSA”, in which homology lengths
are much lower, as the latter process appeared to rely mostly on
RAD59, a budding yeast homolog of RAD52, instead of RAD52
itself (Sugawara et al., 2000). Altogether, studies by the group
of Haber thus pointed toward the possible contribution of HR-
dependent pathways in budding yeast MMEJ, suggesting that this
may not represent a new completely distinct DNA repair pathway
but could reﬂect a micro-SSA-type mechanism of DSB repair. In
complete agreement with these predictions, a study performed in
X. laevis eggs established that a puriﬁed fraction displaying MMEJ
activity contained DNA Ligase III (LIG3), DNA polymerase ε,
FEN-1 endonuclease, and exonuclease activities of 5′–3′ and 3′–5′
directionality and that the same fraction was able to process SSA
intermediates (Gottlich et al., 1998). Next, it was reported that,
in a NHEJ-deﬁcient S. cerevisiae background, MMEJ events were
not dependent on RAD52 but required the MRE11/RAD50/XRS2
complex previously implicated in both NHEJ and HR (Ma et al.,
2003; Yu and Gabriel, 2003). The requirement for RAD59 was
however, not tested. Extrachromosomal DSB repair experiments
in NHEJ-deﬁcient ﬁssion yeast mutants then provided additional
evidences in favor of a SSA-dependent mechanism for MMEJ
(Decottignies, 2007). In this system, both RAD22, the ﬁssion yeast
RAD52 homolog, and EXOl, the 5′–3′ exonuclease involved in
the formation of ssDNA intermediates for HR, were required for
MMEJ (Decottignies, 2007). However, another study conducted
in mouse ES cells concluded that, although the ﬁrst steps may
be shared, alternative NHEJ in ES cells may be distinct from SSA
during the late steps of repair (Bennardo et al., 2008). This conclu-
sion came from the observation that mouse RAD52 was not able
to stimulate alternative NHEJ in their experimental chromoso-
mal context although the protein was able to promote SSA when
the entire coding sequence of GFP was involved in homology-
directed repair (Bennardo et al., 2008). One possibility however,
would be that the annealing process may require another pro-
tein than RAD52, similarly, to the situation in budding yeast
where RAD59, a RAD52 homolog, is required for annealing when
only very short homologous sequences are available for SSA (Sug-
awara et al., 2000). In support of this, observations in RAD52
knock-out mouse models suggested that mouse RAD52 may only
be involved in certain types of DSB repair processes while other
HR-dependent events may be catalyzed by distinct proteins func-
tionally related to RAD52 (Rijkers et al., 1998). This remains to be
tested experimentally.
Additional proteins, whether from yeast or from higher eukary-
otes, were reported to play a role in MMEJ. POL4, a member of the
PolX family of polymerases with gap-ﬁlling activity, and proteins
from the mismatch repair pathways were found to be required for
MMEJ-dependent repair of substrates with non-perfect micro-
homologies in ﬁssion yeast (Decottignies, 2007). The MRE11
complex was found to be required for MMEJ in budding yeast (Ma
et al., 2003), Arabidopsis (Heacock et al., 2004) and human cells
(Delia-Maria et al., 2011), but dispensable for ﬁssion yeast MMEJ
using an extrachromosomalDSB repair assay (Decottignies, 2007).
It is believed however, that ﬁssion yeast MRE11 complex may be
required for MMEJ events in a chromosomal context and/or for
intermolecular MMEJ-dependent ligations (Decottignies, 2005,
2007). As stated above, ﬁrst evidences for the involvement of LIG3
in the MMEJ process were provided by biochemical fractionation
of X. laevis egg extracts (Gottlich et al., 1998). LIG3 contribu-
tion to MMEJ was later conﬁrmed in HeLa cells (Wang et al.,
2005), in human HTD114 cell line (Liang et al., 2008) and in mice
(Simsek et al., 2011).
In mature mouse B cells activated by antigens, recent in vivo
evidences indeed support the existence of a powerful backup
mechanism able to compensate for NHEJ during immunoglob-
ulin class switch recombination (CSR; Soulas-Sprauel et al., 2007;
Yan et al., 2007). Whether this in vivo backup mechanism is sim-
ilar to the MMEJ repair pathway described above is however
still a matter of debate. In favor of this hypothesis, the backup
CSR activity detected in the absence of either XRCC4 or LIG4
was found to operate through the recognition of microhomolo-
gies at DNA break borders and, in agreement with two previous
reports (Audebert et al., 2004; Wang et al., 2005), was proposed
to rely on XRCC1/LIG3 complex (Yan et al., 2007). Interestingly,
XRCC1 was previously involved in SSA (Stark et al., 2004), further
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supporting the view that alternative NHEJ may similarly operate
through a micro-SSA-like mechanism in immune cells. A more
recent study published by the group of Jasin reported that, sim-
ilarly to what happens in human cells in culture, mouse LIG3 is
involved in an alternative end-joining pathway operating through
annealing at pre-existing microhomologies (Simsek et al., 2011).
They proposed that LIG4 was acting as a repressor of the DNA
end resection activity required to produce the complementary
ssDNA ends.
Although the studies reported above in various eukaryotic
species converged onto the identiﬁcation of the alternative end-
joining backup pathway as a microhomology-dependent mech-
anism presumably relying on LIG3, recent data led to revise
this view. Indeed, experiments performed in mammalian cells
suggested the existence of an additional alternative end-joining
pathway presumably relying on Ligase I (LIG1) and able to repair
DSBs independently of pre-existing microhomologies (Boboila
et al., 2010a,b, 2012; Simsek et al., 2011). First in vivo evi-
dences came from the observation that, in either KU70−/− or
KU70−/−/LIG4−/− mice, CSR appears to operate through two
distinct alternative end-joining mechanisms in B cells, with only
one relying on microhomologies (Boboila et al., 2010a). This
newly unraveled alternative end-joining mechanism was not ini-
tially detected in either LIG4−/− or XRCC4−/− mouse B cells for
which microhomologies were recovered at all CSR junctions, sug-
gesting that it may be repressed by Ku70/Ku80. Further support in
favor of the existence of a second alternative end-joining mecha-
nism not relying on pre-existing microhomologies was provided
by sequencing of chromosomal translocation breakpoints recov-
ered in B cells from KU70−/− mice (Boboila et al., 2010b). Shortly
after, using an experimental system of chromosomal transloca-
tion induction based on zinc ﬁnger nuclease-induced DSBs in
mouse cells, the group of Jasin reported that, while transloca-
tion breakpoints displayed less microhomologies in the absence
of LIG3, LIG1 depletion did not affect microhomology use (Sim-
sek et al., 2011). Note however that an in vitro study performed
in human HTD114 cell line reported that both LIG1 and LIG3
were involved in MMEJ-dependent repair of an extrachromoso-
mal DSB, although contribution of LIG3 appeared to be more
important (Liang et al., 2008).
Altogether, data suggest the possible existence of two dis-
tinct alternative end-joining repair processes, both repressed by
Ku70/Ku80 (Figure 2), The ﬁrst one appears to rely on the
presence of microhomologies for repair and I propose that it
operates through a micro-SSA-type mechanism and involves
LIG3. The second pathway of alternative end-joining does not
appear to depend on pre-existingmicrohomologies and is believed
to rely on LIG1. However, evidences for the conservation of
the latter pathway throughout the eukaryotic lineage are still
lacking.
IMPLICATION OF ALTERNATIVE NHEJ IN TELOMERE FUSION
EVENTS
Telomeres at the end of linear chromosomes are reportedly
resistant to end-to-end fusions thanks to the binding of so-
called shelterin proteins (van Steensel et al., 1998). Accord-
ingly, when normal shelterin density is breached, protection
of telomeres against DNA damage activation is no longer
ensured and DNA repair enzymes have access to telomeric
DNA. Hence, loss of TRF2 shelterin component at mammalian
telomeres induces telomere deprotection and LIG4-dependent
fusions (Smogorzewska and de Lange, 2002). Further experi-
ments revealed a direct role for mammalian RAP1/TRF2 com-
plex in protection of telomeric DNA from NHEJ, indepen-
dently of the involvement of TRF2 in telomeric-loop formation
(Bae and Baumann, 2007).
Although NHEJ is clearly able to mediate end-to-end fusions
in a telomere-deﬁcient background, this DNA repair pathway is
not required to catalyze all types of telomere fusions. Indeed,
telomerase-deﬁcient ﬁssion yeast mutants lacking either Ku70
or LIG4 display rearranged telomeres and chromosome circular-
ization, indicating that alternative end-joining mechanisms are
able to promote telomere fusion (Baumann and Cech, 2000).
Similar conclusions were subsequently drawn from studies in
budding yeast (Mieczkowski et al., 2003) and Arabidopsis (Riha
and Shippen, 2003). A molecular analysis was then published
in which authors analyzed telomere fusion events in Arabidop-
sis mutants lacking both TERT catalytic subunit of telomerase
and Ku70 DNA repair protein (Heacock et al., 2004). Fusions
between telomeric and subtelomeric regions of plant chromo-
somes were associated with large deletions, extending to more
than 300 bp, and displayed overlapping homologies of up to
12 bp. Here too, Ku70 was acting as a strong inhibitor of the
MMEJ-dependent mechanism of telomere fusion while MREll
was found to promote fusions (Heacock et al., 2004). Subsequent
work by the same group revealed that, as expected from an alter-
native end-joining mechanism, LIG4 was not required for plant
telomere fusions (Heacock et al., 2007). Studies in human cells
revealed similar mechanisms of telomere fusion in cells forced
to divide in the absence of telomerase. In these cells, telomere
fusions occurred with concomitant deletion of one or both telom-
eres and were characterized by the presence of microhomologies
(Capper et al., 2007; Letsolo et al., 2010).
Following these in vitro studies, a report provided evidences
for the involvement of both NHEJ and MMEJ repair path-
ways in mouse telomere fusion events in vivo (Rai et al., 2010).
Using a combination of mutants and shRNA constructs, the
authors showed that, while TRF2/RAP1 complex protects telom-
eres from ATM activation and NHEJ, single-stranded telomeric
DNA-binding protein POT1, in conjunction with TPP1 shelterin
component, inhibits ATR activation and alternative NHEJ. In
agreement with previous data in human cells, their work further
suggested that alternative NHEJ is the main pathway to pro-
cess dysfunctional telomeres in mouse cells experiencing natural
telomere erosion (Rai et al., 2010). Hence, despite a strong protec-
tion against NHEJ provided by TRF2, mammalian telomeres can
be targets of MMEJ. Elegant demonstration of the role of shelterin
components in telomere end protection was recently provided by
the group of de Lange (Sfeir and de Lange, 2012). They conﬁrmed
the role of TRF2 as repressor of both ATM signaling and clas-
sical NHEJ and the role of POT1 in ATR signaling repression.
They also showed that alternative NHEJ was repressed by vari-
ous shelterin components as well as by Ku70/Ku80 and proposed
that the redundancy of repressors may ensure better protection
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FIGURE 2 | Alternative end-joining pathways of DNA repair.Two types
of alternative end-joining pathways of DSB repair were unraveled in
NHEJ-deﬁcient cells. One pathway, dubbed “microhomology-mediated
end-joining” or MMEJ, relies on pre-existing microhomologies around the
break (in orange) and is likely to operate through a mechanism related to
single strand-annealing (micro-SSA). MMEJ appears to rely on Ligase III
(LIG3) for sealing. Unlike MMEJ, the second alternative pathway, dubbed
Alt-NHEJ, does not require the presence of pre-existing microhomologies
and may rather rely on Ligase I (LIG1). Simsek et al. (2011) proposed that
microhomologies may nevertheless be generated by a polymerase
activity (Pol) operating at one DNA end. The same study suggested that
LIG1 may only function in the absence of LIG3 as a back-up ligase, at least
in mouse cells. Both MMEJ and Alt-NHEJ are repressed by the NHEJ
machinery (Ku70/Ku80, LIG4/XRCC4). The MRX complex is likely to play
important roles for both alternative pathways during the ﬁrst steps
of repair.
against dangerous alternative NHEJ at telomeres (Sfeir and de
Lange, 2012).
Hence, the above studies clearly pointed toward an important
contribution of alternative NHEJ to pathologic chromosome
fusion events in cells with dysfunctional telomeres. Although evi-
dences for an involvement of SSA proteins in these end-joining
events is still lacking, telomere fusions are characterized by micro-
homologies at junctions, are repressed by Ku70/Ku80 and rely on
the MRE11 complex in plants and possibly also in human cells
(Tankimanova et al., 2012).
MUTAGENIC POTENTIAL OF ALTERNATIVE NHEJ IN
MAMMALS
In the late 1990s, it became evident that NHEJ acts as a tumor sup-
pressing mechanism. Indeed, mice lacking both p53 and a NHEJ
component, like DNA-PKcs, Ku80, XRCC4, or LIG4, were found
to die in early postnatal life due to an elevated frequency of B cell
lymphomas displaying IgH-Myc translocations and ampliﬁcations
(reviewed in Sharpless et al., 2001). Importantly, these lymphomas
were qualitatively distinct from those arising in a p53-deﬁcient
background alone as, in the latter mouse mutants, tumors had
a later onset and did not generally harbor translocations. Fol-
lowing these observations, IgH-Myc translocation junctions were
recovered from XRCC4−/−/p53−/− mice in order to charac-
terize the DNA repair mechanisms involved in chromosomal
translocations. Sequencing of breakpoint junctions revealed the
presence of microhomologous DNA sequences (Zhu et al., 2002;
Wang et al., 2008). LIG4 haploinsufﬁciency was also reported to
increase sarcoma formation in INK4a/ARF−/− mice by induc-
ing chromosomal translocations, ampliﬁcations and deletions but
translocation junctions were not characterized (Sharpless et al.,
2001). In a more recent report, the group of F. Alt conﬁrmed that
an alternative end-joining pathway robustly catalyzes transloca-
tions in KU70−/−/LIG4−/− mice B cells that are fully deﬁcient
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for classical NHEJ (Boboila et al., 2010b). However, as the authors
did not detect any bias toward MMEJ at breakpoint junctions, they
suggested that translocations were mediated by an alternative end-
joining mechanism not relying on microhomologies. It should be
tested whether this mutagenic alternative end-joining mechanism
operating in B cells of KU70−/− mice requires LIG1.
In human, an analysis of high-grade bladder carcinomas sug-
gested that MMEJ may contribute to the high genomic instability
of bladder cancer (Bentley et al., 2004). Indeed, authors showed
that these tumors were highly proﬁcient in their ability to perform
MMEJ, even though Ku, DNA-PKcs and XRCC4 proteins were
expressed at normal level.
Altogether, data reported so far indicate that, although the clas-
sical LIG4/Ku-dependent NHEJ pathway appears to act as a potent
tumor suppressor mechanism, alternative end-joining pathways,
whether relying on microhomologies or not, promote chromo-
somal translocations. In the future, it would be interesting to
better characterize these alternative pathways of end-joining and
to identify the genes involved in the repair processes.
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